Trial Profile
An Observational Study of Dose Dense Chemotherapy With Lipegfilgrastim Support
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Mar 2023
Price :
$35
*
At a glance
- Drugs Cyclophosphamide (Primary) ; Doxorubicin (Primary) ; Lipegfilgrastim (Primary)
- Indications Early breast cancer; Neutropenia
- Focus Adverse reactions
- 20 Feb 2023 Results published in the BMC Cancer
- 09 Feb 2018 Status changed from active, no longer recruiting to completed.
- 22 Jul 2016 Status changed from recruiting to active, no longer recruiting.